Skip to main content
. Author manuscript; available in PMC: 2009 Apr 30.
Published in final edited form as: Neuropsychopharmacology. 2008 Oct 15;34(1):18–54. doi: 10.1038/npp.2008.172

Figure 1.

Figure 1

Gene-based drug discovery strategies based on disease-specific (left) and drug-induced (right) mRNA expression changes. Information from these data, the literature, and other factors described in the text are used to select a smaller set of genes that change reciprocally between human brain and drug-exposed tissue, and are used for gene-based compound screening or identification of specific targets.